Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To assess the effects of Acetyl-L-Carnitine, probiotics and antioxidant nutritional
substances administration on work productivity, daily activity, and fatigue in subjects with
chronic hepatitis C treated with Pegylated-Interferon-α2b and Ribavirin.